November 14th, 2011
What’s Up, Interventionally?
Eiman Jahangir, MD
Martin Leon surveys the expansion of the interventionalist’s world
November 14th, 2011
Global CV Health Concerns: Macro and Micro
Eiman Jahangir, MD
Now I know how I should approach and present myself to a potential mentor. But will it really take at least 10 years to train in research?
November 14th, 2011
PALLAS: Poor Results for Dronedarone in Permanent AF
Larry Husten, PHD
After a brief announcement earlier this year that the trial had been terminated early, the full results of PALLAS (Permanent Atrial Fibrillation Outcomes Study Using Dronedarone on Top of Standard Therapy) have now been presented at the AHA and published simultaneously in the New England Journal of Medicine. PALLAS shows that dronedarone (Multaq, Sanofi) should not be used in patients […]
November 14th, 2011
Stenosis vs. Stroke: Is Treatment Worth the Risk?
Eiman Jahangir, MD
Several Cardiology Fellows who are attending AHA.11 this week are blogging together on CardioExchange. The Fellows include Revathi Balakrishnan, Eiman Jahangir, John Ryan (moderator), and Amit Shah. Read the previous post here. Check back often to learn about the biggest buzz in Orlando. On Sunday morning, I feel like the conference has really begun. I am […]
November 14th, 2011
At AHA, the Title Says It All
David Martin, M.D.
. . . or almost. Here are some abstract and session titles that have caught my eye so far: Nightmares in the Cath Lab. A session where fellows presented cases gone wrong. I missed this one and sorry I did. Wonder if TCT had anything similar. My Most Challenging Cases: Shock and Awe in the […]
November 14th, 2011
“The Center Where It All Happens”
Reva Balakrishnan, MD, MPH
Several Cardiology Fellows who are attending AHA.11 this week are blogging together on CardioExchange. The Fellows include Revathi Balakrishnan, Eiman Jahangir, John Ryan (moderator), and Amit Shah. Read the previous post here. Check back often to learn about the biggest buzz in Orlando. For this first-year fellow, the AHA has seemed at times like the “light […]
November 14th, 2011
MI FREEE: How Much Do Free Medications Really Cost?
Larry Husten, PHD
Could getting rid of copayments improve adherence to post-discharge medications, leading to better outcomes and reduced costs? That’s the theory tested by the MI FREEE (Post-Myocardial Infarction Free Rx Event and Economic Evaluation) trial, which was presented at the AHA and published simultaneously in the New England Journal of Medicine. Niteesh Choudhry and colleagues randomized 5855 post-MI […]
November 13th, 2011
What Will Keep Me Coming Back to AHA?
John Ryan, MD
A special seminar dedicated to emerging concepts of the right ventricle is exemplary of the kind of content that makes AHA worth the journey.
November 13th, 2011
Not Just Pomp and Circumstance
David Martin, M.D.
The AHA Opening Session is something I usually avoid, maybe because I feel a bit uncomfortable in large, dark rooms with flashing lights and very loud music (a setup that seems to favor the visually gifted but audiologically impaired). Admittedly, when the recipients of the Distinguished Scientist awards were paraded across the stage to a […]
November 13th, 2011
AHA’s Best-Kept Secrets
David Martin, M.D.
Late breakers and plenaries aside, a few perennial AHA conference sessions are, I think, often overlooked: Early Career Sessions. Not just for early career folk, these sessions allow any attendee to hear scientific luminaries talk about why and how they do what they do. Where else might you catch Joe Loscalzo describing how the early […]